The ECHO study began in December 2015, when two sites in South Africa started screening and enrolling participants. The randomised clinical trial recruited a total of 7,830 sexually active HIV-negative women aged 16 to 35 at 12 study sites in Kenya, South Africa, Swaziland and Zambia. In August 2017, the study achieved its enrollment target.